Curt Creely, partner with Foley & Lardner LLP, is a member of the firm’s Transactional & Securities and Private Equity & Venture Capital Practices. He is also a member of the firm's Life Sciences and Technology Industry Teams.
Mr. Creely's practice focuses on counseling companies, investors, investment banking firms, and entrepreneurs in connection with public and private securities offerings, mergers and acquisitions, joint ventures, strategic transactions, securities law compliance and reporting, corporate governance matters, loan transactions, and company formation.
Mr. Creely has served as principal issuer’s counsel in initial public offerings by technology and life sciences companies, and he regularly advises public companies in various industries on SEC compliance, reporting, and governance matters. He also represents issuers and investors in venture capital, private equity, and private placement transactions. He regularly serves as counsel in merger and acquisition transactions involving private and public companies in various industries, including healthcare, software, financial services, and life sciences. He also represents businesses in technology-driven strategic transactions, including joint ventures, technology licensing transactions, and product development and collaboration programs.
In 2015, The Legal 500 recommended Mr. Creely for his work in the area of mergers and acquisitions. He also has been selected by his peers for inclusion in The Best Lawyers in America© in the fields of mergers & acquisitions and securities law. In 2013, International Law Office and Lexology recognized him with a Client Choice award for his work in capital markets.
Mr. Creely graduated with high honors from the University of Florida College of Law in 1995, where he was a member of the Florida Law Review and was elected to Order of the Coif. He received his bachelor's degree summa cum laude in history and political science from Geneva College in 1992, where he was co-valedictorian of his graduating class.
Personalized Medicine Investors: Who Are They and What Are They Thinking?
9:30 AM - 10:40 AM